Aarti Pharmalabs Limited — Board Meeting, 10-05-2025: Outcome of Board Meeting

Aarti Pharmalabs has announced a board meeting to approve the financial results for the quarter and year ended March 31, 2025. The company declared a dividend of Rs. 2.50 per share (50% of face value), subject to shareholder approval. Smt. Ketki D. Visariya was appointed as Cost Auditor and Manish Modi & Associates as Internal Auditor for FY 2025-26, reinforcing the firm’s commitment to strong financial oversight while rewarding shareholders.